ASCVD Risk Estimator

Calculates the 10-year risk of heart disease or stroke. Uses the 2013 ACC/AHA Pooled Cohort Equations.

Age (40-79 years)

Sex

Male Female

Race

White/Other African American

Total Cholesterol (130-320 mg/dL)

HDL Cholesterol (20-100 mg/dL)

Systolic BP (90-200 mmHg)

Treatment for High Blood Pressure

Diabetes

Current Smoker

10-Year ASCVD Risk

Please enter valid values for Age (40-79), Total Cholesterol (130-320), HDL (20-100), and Systolic BP (90-200) to calculate risk.

Guidance for Statin Therapy

Based on the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol:

≥ 20% (High Risk): High-intensity statin to reduce LDL-C by ≥ 50%.
7.5% to < 20% (Intermediate Risk): Moderate-intensity statin to reduce LDL-C by 30-49%. Consider risk-enhancing factors.
5% to < 7.5% (Borderline Risk): Consider moderate-intensity statin if risk-enhancing factors are present.
< 5% (Low Risk): Emphasize lifestyle to reduce risk factors.

Assumptions & Limitations

The pooled cohort equations are validated for patients aged 40-79 without clinical ASCVD. If the patient has established cardiovascular disease (prior MI, stroke, PAD), they are in a secondary prevention group and automatically require high-intensity statin therapy, rendering this score unnecessary.